Czy oni nas oszukują. Kopia z YT.

. In vitro and in vivo suppression of growth of hepatocellular carcinoma cells by albendazole
https://www.sciencedirect.com/science/article/abs/pii/S0304383501003822

2 https://pubmed.ncbi.nlm.nih.gov/15630849/

The contribution of cytotoxic chemotherapy to 5-year survival in adult malignancies

3.
The contribution of cytotoxic chemotherapy to 5-year survival in adult malignancies
https://pubmed.ncbi.nlm.nih.gov/15630849/

4.
Neoadjuvant chemotherapy induces breast cancer metastasis through a TMEM-mediated mechanism
https://pubmed.ncbi.nlm.nih.gov/28679654/

5.
A systematic overview of chemotherapy effects in colorectal cancer
https://pubmed.ncbi.nlm.nih.gov/11441937/

6.
A systematic overview of chemotherapy effects in ovarian cancer
https://pubmed.ncbi.nlm.nih.gov/11441940/

7.
https://www.cancer.org/ doc not found

8.
Review of Drug Repositioning Approaches and Resources
https://pubmed.ncbi.nlm.nih.gov/30123072/

9.The Antitumor Potentials of Benzimidazole Anthelmintics as Repurposing Drugs
https://pubmed.ncbi.nlm.nih.gov/32895616/

10.
Anti-cancer effect of fenbendazole-incorporated PLGA nanoparticles in ovarian cancer
https://pubmed.ncbi.nlm.nih.gov/37170725/

Epothilone-paclitaxel resistant leukemic cells CEM/dEpoB300 are sensitive to albendazole: Involvement of apoptotic pathways
https://pubmed.ncbi.nlm.nih.gov/17560963/

Antiproliferative effect of benzimidazole anthelmintics albendazole, ricobendazole, and flubendazole in intestinal cancer cell lines
https://pubmed.ncbi.nlm.nih.gov/23884106/

11.
Albendazole: a potent inhibitor of vascular endothelial growth factor and malignant ascites formation in OVCAR-3 tumor-bearing nude mice
https://pubmed.ncbi.nlm.nih.gov/16551879/

Potent inhibition of tubulin polymerisation and proliferation of paclitaxel-resistant 1A9PTX22 human ovarian cancer cells by albendazole
https://pubmed.ncbi.nlm.nih.gov/19846910/

Repurposing Mebendazole as a Replacement for Vincristine for the Treatment of Brain Tumors
https://pubmed.ncbi.nlm.nih.gov/28386621/

Unbiased Phenotype-Based Screen Identifies Therapeutic Agents Selective for Metastatic Prostate Cancer
https://pubmed.ncbi.nlm.nih.gov/33738243/

Albendazole: a potent inhibitor of vascular endothelial growth factor and malignant ascites formation in OVCAR-3 tumor-bearing nude mice
https://pubmed.ncbi.nlm.nih.gov/16551879/

12.
https://doi.org/10.15252/emmm.201404081 not found

Antitumor activity of albendazole against the human colorectal cancer cell line HT-29: in vitro and in a xenograft model of peritoneal carcinomatosis
https://pubmed.ncbi.nlm.nih.gov/15565325/

AR42, a novel histone deacetylase inhibitor, as a potential therapy for vestibular schwannomas and meningiomas
https://academic.oup.com/neuro-oncology/article-abstract/13/9/983/1094204?redirectedFrom=fulltext&login=false /no acces/

Repurposing Mebendazole as a Replacement for Vincristine for the Treatment of Brain Tumors
https://pubmed.ncbi.nlm.nih.gov/28386621/

The Antitumor Potentials of Benzimidazole Anthelmintics as Repurposing Drugs
https://pubmed.ncbi.nlm.nih.gov/32895616/

Ivermectin inhibits tumor metastasis by regulating the Wnt/β-catenin/integrin β1/FAK signaling pathway
https://pubmed.ncbi.nlm.nih.gov/36381328/

[Frequency of delayed-type nausea and vomiting in patients treated with cisplatin, and factors affecting these symptoms]
https://pubmed.ncbi.nlm.nih.gov/3373824/

Albendazole: a potent inhibitor of vascular endothelial growth factor and malignant ascites formation in OVCAR-3 tumor-bearing nude mice
https://pubmed.ncbi.nlm.nih.gov/16551879/

[BMIm]2[Mn(CO)3(GeI3)3]: Carbonyl Compound with an {MnGe3} Cluster Unit
https://pubmed.ncbi.nlm.nih.gov/32845616/

Wspieraj Wolne Media! Wykup subskrypcję PL1VOD.com i uzyskaj dostęp do wszystkich nagrań telewizji PL1.tv oraz do prenumeraty tygodnika "Warszawska Gazeta" i dwumiesięcznika "Zakazana Historia". Subskrybenci mogą również słuchać wybranych artykułów w wersji audio, a dostęp do wydań elektronicznych dostają wcześniej niż są one dostępne w kioskach.

Wejdź na www.pl1vod.com/wykup-subskrypcje i wybierz odpowiadający Ci pakiet!
Jeżeli chcesz nas wesprzeć dowolną sumą, wpłać darowiznę:
https://pl1vod.com/wspieraj-wolne-media/

Zapraszamy na nasze sociale:
𝐏𝐋𝟏𝐕𝐎𝐃: https://pl1vod.com/